About the RPR Test
Purpose of the test
The RPR test screens for syphilis, a bacterial sexually transmitted infection (STI) caused by Treponema pallidum. It also tracks whether treatment is working. Syphilis spreads through vaginal, anal, or oral sex and can pass from a pregnant person to their baby. It’s fully curable with antibiotics, but cases have been climbing nationwide for over a decade, according to CDC STI surveillance data.
Syphilis develops in stages: primary, secondary, latent, and tertiary. Depending on the stage, no symptoms may be evident. Testing is the only reliable way to know your status.
In pregnancy, untreated syphilis can cause miscarriage, stillbirth, or severe problems for the baby (congenital syphilis), as described in the CDC’s syphilis disease education resource. That’s why routine screening during prenatal care matters so much.
A reactive RPR alone doesn’t mean you have syphilis. False positive results can occur due to pregnancy, IV drug use, tuberculosis, chronic liver disease, recent vaccinations, or heart inflammation. The test doesn’t detect Treponema pallidum directly, and it doesn’t screen for other STIs. A confirmatory treponemal test is always needed to tell true infection apart from a biological false positive.
The test serves three purposes:
- Screening: The CDC recommends routine RPR screening for all pregnant people and for sexually active people at higher risk.
- Diagnosis: Consider this test if you have symptoms like a painless sore, a rash on your palms or soles, or swollen lymph nodes.
- Monitoring: After treatment, the RPR tracks whether your antibody levels (titers) are dropping, which shows the infection is clearing.
What does the RPR test measure?
The RPR test covers one marker from a single blood sample processed at a CLIA-certified lab.
- Rapid Plasma Reagin (RPR): Detects non-treponemal antibodies your body produces when syphilis damages tissue, signaling possible infection.
Results come in two forms: qualitative (reactive or non-reactive) and quantitative (a titer reported as a ratio like 1:2, 1:4, 1:8, or 1:32). Higher ratios generally point to more active or recent infection. Falling titers after treatment are the key sign the infection is clearing.
- Qualitative RPR: Reports reactive or non-reactive; the preferred tests used for initial screening
- Quantitative RPR (titer): Reports a ratio like 1:8; used when the qualitative result is reactive and for tracking treatment response
- VDRL (Venereal Disease Research Laboratory) test: An older non-treponemal test with the same screening role as the RPR; still used for cerebrospinal fluid testing when neurosyphilis is suspected
- Treponemal confirmatory tests (FTA-ABS, TP-PA): Detect antibodies specific to Treponema pallidum; used to confirm a reactive RPR; stay reactive for life even after successful treatment
Once treated, most will have a negative RPR test, yet some may show low-level reactivity. Treponeal tests show permanent reactivity, even after a full cure. That’s why the RPR titer, not the treponemal test, tracks treatment response. A reactive RPR test years later doesn’t mean you’re still infected.
When should I get an RPR test?
Consider testing if any of these apply:
- A possible exposure to syphilis through sexual contact
- A sexual partner recently diagnosed with syphilis or another STI
- Symptoms like a painless sore, rash on your palms or soles, or swollen lymph nodes
- A current pregnancy (at first prenatal visit)
- A new sex partner or multiple sex partners
- An HIV diagnosis or current use of PrEP (pre-exposure prophylaxis)
- Inconsistent condom use
- A prior syphilis diagnosis and completed treatment (for monitoring)
For routine screening, the CDC recommends:
- Women at increased risk (history of incarceration or transactional sex work, geography, or race/ethnicity): screening as clinically indicated
- Gay, bisexual, and other men who have sex with men (MSM): at least annual; every three to six months if at higher risk
- Pregnant people: at first prenatal visit; rescreen at 28 weeks gestation and at delivery if at increased risk due to geography or personal risk factors
- Anyone diagnosed with HIV: at first HIV evaluation and at least annually after that
- Anyone previously treated for syphilis: follow-up RPR at six and 12 months after treatment
The U.S. Preventive Services Task Force also recommends screening for syphilis infection in persons who are at increased risk for infection.
How It Works
How to get tested
The RPR test is ordered through a healthcare provider, clinic, or hospital lab. CLIA-certified labs including LabCorp and Quest Diagnostics process most U.S. RPR tests. A provider orders the test, you go to a partner lab or the provider’s office for a blood draw, and results come back through the ordering provider’s patient portal or office.
For the RPR test, no urine sample, swab, or physical exam is involved. It’s a blood draw from a vein in your arm. No fasting or special prep is needed.
If your RPR result is reactive, many labs automatically run a treponemal confirmatory test on the same sample. Your final report may include both results.
Want to test privately from home? Syphilis is included in the at-home STD test. That kit screens for chlamydia, gonorrhea, syphilis, HIV, herpes, hepatitis B, and trichomoniasis from a self-collected sample.
Before the test
No fasting required. Eat and drink normally.
Tell your provider about any current medications and any conditions that could affect how your results are read. Pregnancy, autoimmune conditions like lupus, and recent viral infections can all trigger a biological false positive on the RPR. Sharing this upfront helps your provider read your results in context.
A few practical tips:
- Wear clothing that gives easy access to your arm
- Drink water beforehand; staying hydrated makes the draw easier
- If you have a latex allergy, tell the lab technician before the draw
During the test
- Check in at the lab with a photo ID and your test order.
- A technician draws blood from a vein in your arm. You’ll feel a brief pinch when the needle goes in.
- A small bandage covers the site. Keep it on for at least 15 minutes to ensure bleeding has stopped.
The draw takes a few minutes. You can leave right away.
Some people feel light-headed after a blood draw, especially if they haven’t eaten recently. Sit for a few minutes if that happens. Mild bruising or soreness at the site over the next day or two is normal. Call your provider if you notice lasting pain, swelling, or signs of infection at the draw site.
After the test
Results are typically ready within one to three business days after the lab receives your sample, though timing can vary by lab. They’ll come back through your ordering provider’s patient portal or office.
If your RPR is reactive, many labs automatically run a treponemal confirmatory test on the same sample. Your report may show two results: the RPR screen and the confirmatory test. Don’t panic if you see both. That’s the expected workflow, not a sign something is wrong.
What Do My Results Mean?
Your RPR report shows one of two results: reactive or non-reactive. If the RPR is reactive, most labs automatically run a treponemal confirmatory test on the same sample. Your report may include both.
If your results are non-reactive
No syphilis antibodies were detected. That’s the equivalent of a negative result.
Keep in mind: if you tested within three to six weeks of a possible exposure, the antibodies may not have shown up yet. A non-reactive result early in that window doesn’t rule out infection. If you had a confirmed exposure, retest after the window has passed.
If you have no known exposure and no symptoms, no further testing is needed. But if symptoms continue despite a non-reactive result, talk with your provider. Other conditions can cause similar symptoms.
If your results are reactive
Syphilis antibodies were detected. But a reactive RPR isn’t a diagnosis on its own.
The RPR picks up non-treponemal antibodies that aren’t specific to Treponema pallidum. Certain conditions can trigger a reactive result without syphilis being present: pregnancy, autoimmune conditions like lupus or antiphospholipid syndrome, some viral infections, and Lyme disease. The treponemal confirmatory test (FTA-ABS or TP-PA) sorts out whether the result reflects true infection, past treated infection, or a biological false positive.
If the lab ran a quantitative RPR, your report includes a titer ratio. Higher ratios (like 1:32) suggest more active or recent infection. After treatment, falling titers show the infection is responding. A titer that doesn’t fall may mean you need further evaluation.
If both the RPR and the treponemal confirmatory test are reactive, that may indicate past or present syphilis exposure. Treponemal tests stay reactive for life, even after a full cure. A reactive treponemal result alone doesn’t tell you whether the infection is currently active. That’s why the RPR titer is the monitoring tool.
Syphilis is curable with antibiotics. Notify recent sexual partners so they can get tested. The CDC’s syphilis treatment guidelines recommend HIV testing for everyone diagnosed with syphilis. Follow up with your provider for treatment and RPR retesting at six and 12 months.
FAQs
Sources
CDC. STI Surveillance Data. 2024.
CDC. Sexually Transmitted Infections Treatment Guidelines, 2021. Screening Recommendations.